High-dose carvedilol improved LV outflow tract velocity, myocardial function, and reduced cTnI levels without adverse effects in cats with Stage B1 obstructive HCM.
Does high-dose carvedilol improve LVOTV, myocardial function, and cTnI levels in cats with Stage B1 obstructive hypertrophic cardiomyopathy?
High-dose carvedilol improves hemodynamic and biomarker profiles in a feline model of obstructive hypertrophic cardiomyopathy without adverse effects.
Absolute Event Rate: 0% vs 0%
HD improved LVOTV, myocardial function, and cTnI level without adverse effects in cats with Stage B1 oHCM.
Satomi et al. (Fri,) reported a other. High-dose carvedilol improved LV outflow tract velocity, myocardial function, and reduced cTnI levels without adverse effects in cats with Stage B1 obstructive HCM.